Topic: Experimental Drugs
In its fourth-quarter earnings out early Friday morning, U.K.-based Big Pharma AstraZeneca has cut two early-stage experimental meds.
Acer Therapeutics’ stock plummeted more than 78% premarket this morning on news that the FDA had rejected approval of its drug Edsivo (celiprolol).
The Democratic Republic of Congo has approved four experimental treatments to help contain the Ebola outbreak, including one in development at Gilead.
The House voted 250-169 to pass a "right-to-try" bill that would allow terminally ill patients access to experimental drugs.
Republicans plan to return to the topic and could push legislation through under rules that would only require them to get a majority.